Synmosa Biopharma Corporation (TPEX:4114)
Taiwan
· Delayed Price · Currency is TWD 36.55
+0.15 (0.41%)
Jun 27, 2025, 1:30 PM CST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Generic Drugs | 4.96B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Generic Drugs Growth | 17.05% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Active Pharmaceutical Ingredients | 179.59M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Active Pharmaceutical Ingredients Growth | 21.37% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Taiwan | 4.37B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Taiwan Growth | 12.69% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China | 534.01M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
China Growth | 96.52% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Thailand | 54.56M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Thailand Growth | 37.79% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Singapore | 41.91M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Malaysia | 36.45M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Malaysia Growth | 18.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States | 28.78M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
United States Growth | -54.12% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Canada | 15.50M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Canada Growth | -55.68% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | 60.80M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | -13.28% |
Log In |
Log In |
Log In |
Log In | Upgrade
|